Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)2.73
  • Today's Change-0.03 / -1.09%
  • Shares traded28.89k
  • 1 Year change+62.99%
  • Beta2.2810
Data delayed at least 15 minutes, as of May 16 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments20498186
Total Receivables, Net231831
Total Inventory--00
Prepaid expenses5.726.778.22
Other current assets, total0.340.00--
Total current assets233122225
Property, plant & equipment, net93108148
Goodwill, net------
Intangibles, net0.670.721.85
Long term investments7.858.796.52
Note receivable - long term------
Other long term assets--0--
Total assets334261382
LIABILITIES
Accounts payable192124
Accrued expenses9.379.4212
Notes payable/short-term debt000
Current portion long-term debt/capital leases8.507.878.33
Other current liabilities, total1189.384.77
Total current liabilities1554849
Total long term debt927092
Total debt10178100
Deferred income tax0.16----
Minority interest07.9715
Other liabilities, total2.20174.70
Total liabilities250143161
SHAREHOLDERS EQUITY
Common stock4.372.962.95
Additional paid-in capital523583935
Retained earnings (accumulated deficit)(406)(440)(698)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(37)(29)(18)
Total equity85118221
Total liabilities & shareholders' equity334261382
Total common shares outstanding724645
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.